Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,916 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $335.61 | 4 | $0 (2024) |
| Amgen Inc. | $332.40 | 3 | $0 (2020) |
| Celgene Corporation | $226.22 | 2 | $0 (2019) |
| Sientra, Inc. | $196.65 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $124.40 | 1 | $0 (2017) |
| Sun Pharmaceutical Industries Inc. | $108.76 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $102.95 | 1 | $0 (2017) |
| Incyte Corporation | $100.70 | 1 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $99.99 | 1 | $0 (2020) |
| PFIZER INC. | $85.68 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.18 | 1 | Regeneron Healthcare Solutions, Inc. ($16.18) |
| 2022 | $378.96 | 4 | Sientra, Inc. ($148.03) |
| 2021 | $11.32 | 1 | MERZ NORTH AMERICA, INC. ($11.32) |
| 2020 | $306.53 | 8 | Amgen Inc. ($123.01) |
| 2019 | $448.88 | 6 | Regeneron Healthcare Solutions, Inc. ($214.47) |
| 2018 | $125.69 | 2 | Regeneron Healthcare Solutions, Inc. ($104.96) |
| 2017 | $628.75 | 6 | Amgen Inc. ($209.39) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/14/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $100.70 | General |
| Category: Dermatology | ||||||
| 06/06/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Immunology | ||||||
| 02/11/2022 | Sientra, Inc. | SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $148.03 | General |
| Category: BREAST AUGMENTATION & RECONSTRUCTION | ||||||
| 01/12/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $108.76 | General |
| Category: Dermatology | ||||||
| 04/09/2021 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $11.32 | General |
| 12/23/2020 | Sientra, Inc. | SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $11.31 | General |
| Category: BREAST AUGMENTATION & RECONSTRUCTION | ||||||
| 12/03/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | — | Food and Beverage | In-kind items and services | $11.50 | General |
| 11/11/2020 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| 10/28/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $123.01 | General |
| Category: Inflammation | ||||||
| 08/20/2020 | Sientra, Inc. | SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: BREAST AUGMENTATION & RECONSTRUCTION | ||||||
| 06/19/2020 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.60 | General |
| 06/17/2020 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.02 | General |
| 02/06/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $99.99 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $103.98 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Immunology | ||||||
| 08/12/2019 | Sientra, Inc. | SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $21.34 | General |
| Category: BREAST AUGMENTATION & RECONSTRUCTION | ||||||
| 06/17/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $85.68 | General |
| Category: DERMATOLOGY | ||||||
| 06/12/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $110.85 | General |
| Category: Dermatology | ||||||
| 05/09/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $110.49 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: DERMATOLOGY | ||||||
| 03/08/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $104.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2017 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $97.12 | General |
| Category: Inflammation | ||||||
| 06/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Finacea (Drug) | Food and Beverage | In-kind items and services | $102.95 | General |
| Category: Dermatology | ||||||
| 06/07/2017 | Allergan Inc. | ACZONE (Drug) | Food and Beverage | In-kind items and services | $76.64 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 234 | 283 | $50,019 | $20,137 |
| 2022 | 12 | 302 | 329 | $68,224 | $28,131 |
| 2021 | 10 | 269 | 330 | $55,743 | $22,935 |
| 2020 | 10 | 295 | 367 | $65,565 | $23,836 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 65 | 65 | $10,920 | $4,820 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 71 | $8,165 | $4,266 | 52.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $6,832 | $2,478 | 36.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 12 | 13 | $5,564 | $2,450 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $4,788 | $2,166 | 45.2% |
| 11106 | Incision biopsy, first skin growth | Office | 2023 | 13 | 13 | $3,120 | $1,397 | 44.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 17 | 22 | $2,486 | $942.94 | 37.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Facility | 2023 | 12 | 13 | $4,914 | $797.19 | 16.2% |
| 11107 | Incision biopsy, each additional skin growth | Office | 2023 | 12 | 13 | $1,430 | $671.95 | 47.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 14 | 36 | $1,800 | $148.01 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $14,455 | $5,941 | 41.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 20 | 20 | $8,560 | $4,454 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 70 | $8,050 | $3,868 | 48.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 18 | 18 | $7,686 | $3,348 | 43.6% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2022 | 15 | 17 | $7,344 | $2,414 | 32.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 19 | 20 | $7,560 | $1,984 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,332 | $1,644 | 37.9% |
| 11106 | Incision biopsy, first skin growth | Office | 2022 | 12 | 12 | $2,880 | $1,228 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $2,100 | $1,087 | 51.8% |
| 11107 | Incision biopsy, each additional skin growth | Office | 2022 | 12 | 16 | $1,760 | $774.10 | 44.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 18 | $1,350 | $752.00 | 55.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 17 | 19 | $2,147 | $635.11 | 29.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 95 | 95 | $16,025 | $6,494 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 81 | $9,440 | $4,948 | 52.4% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 15 | 15 | $6,420 | $2,953 | 46.0% |
About Bruce Barton
Bruce Barton is a Plastic Surgery healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912058132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bruce Barton has received a total of $1,916 in payments from pharmaceutical and medical device companies, with $16.18 received in 2024. These payments were reported across 28 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,916).
As a Medicare-enrolled provider, Barton has provided services to 1,100 Medicare beneficiaries, totaling 1,309 services with total Medicare billing of $95,039. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Plastic Surgery
- Location Lexington, KY
- Active Since 01/15/2007
- Last Updated 05/20/2008
- Taxonomy Code 208200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912058132
Products in Payments
- Otezla (Drug) $349.23
- LIBTAYO (Biological) $214.47
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) $196.65
- COSENTYX (Biological) $124.40
- Winlevi (Drug) $108.76
- DUPIXENT DUPILUMAB INJECTION (Biological) $104.96
- Finacea (Drug) $102.95
- OPZELURA (Drug) $100.70
- SILIQ (Drug) $99.99
- Enbrel (Biological) $97.12
- EUCRISA (Drug) $85.68
- ACZONE (Drug) $76.64
- DUPIXENT (Biological) $37.65
- XEOMIN (Biological) $20.73
- Cimzia (Drug) $16.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Plastic Surgery Doctors in Lexington
David Kirn, M.d, M.D
Plastic Surgery — Payments: $4.3M
Stephen Schantz, M.d, M.D
Plastic Surgery — Payments: $31,649
Jared Nimtz, Md, MD
Plastic Surgery — Payments: $11,424
Jessica Walker, M.d, M.D
Plastic Surgery — Payments: $6,554
Monica Hall-Robertson, Md, MD
Plastic Surgery — Payments: $6,436
Dr. Joseph Hill, M.d, M.D
Plastic Surgery — Payments: $5,533